Other prescribing guidelines
- Wessex palliative care guidelines
- gastro-intestinal system
- cardiovascular system
- respiratory system
- central nervous system
- infections
- endocrine system
- obstetrics, gynaecology and urinary-tract disorders
- malignant disease and immunosuppression
- nutrition and blood
- musculoskeletal joint diseases
- eye
- ear, nose and oropharynx
- skin
- immunological products and vaccines
- anaesthesia
Gastro-intestinal system
Guidelines currently unavailable. They will be added here when released.
Cardiovascular system
- statement on the use of generic clopidogrel
- care pathway for the use of prasugrel for diabetic patients
- dual antiplatelet therapy in acute coronary syndrome
- commissioning statement for ivabradine
- commissioning statement for bivalirudin
- commissioning statement for dabigatran or rivaroxaban for patients with AF
- Rivaroxaban prescribing guideline
- flow chart to support the use of anticoagulants in patients with AF
- quick reference guide for primary care for dabigatran or rivaroxaban for patients with AF
Respiratory system
- Dorset COPD treatment guideline
- commissioning statement for NAC
- NICE TA 266 mannitol
- Flutiform® commissioning statement
Central nervous system
- Benzodiazepine prescribing support pack
- primary care protocol for depression
- primary care protocol for anxiety
- guidance on the use of antipsychotics for conditions other than schizophrenia
- pharmacological intervention in ADHD
- management of neuropathic pain
- guideline for the management of axillary hyperhidrosis
- pharmacological management of Parkinson's Disease
- guideline for paracetamol use RBCH
Infections
- Antibiotic formulary 2009 NHS Bournemouth and Poole
- Hampshire and Isle of Wight Guidelines for Antibiotic Prescribing in the Community 2012
- NICE TA 276 colistimethate sodium and tobramycin dry powders
Endocrine system
- monitoring in type 2 diabetes
- Type II diabetes human insulin guidelines
- guideline for the pharmacological management of diabetic neuropathic pain in primary care
- commissioning statement for the use of growth hormone in children and adults
- Medical management of glucocorticoid-induced osteoporosis
- NICE TA 265 denosumab
- EMA RECOMMENDATION TO RESTRICT STRONTIUM USAGE
- Management of osteoporosis
- Long term use of bisphosphonates
Obstetrics, gynaecology and urinary-tract disorders
Malignant disease and immunosuppression
- beta-interferon in MS commissioning statement
- Biliary Tract Tumours
- Brain cancer algorithm
- Brain cancer standard regimens
- Breast Adjuvant DRAFT chemo algorithm
- Breast Advanced DRAFT chemo algorithm
- Cervical cancer chemo algorithm
- Chemotherapy for community administration
- Colorectal cancer Adjuvant DRAFT chemo algorithm
- Colorectal cancer Advanced DRAFT chemo algorithm
- Endocrine cancer DRAFT standard regimen list
- Endometrial cancer chemo algorithm
- Gastro-Intestinal stromal algorithm
- Gynae Cancer standard regimens
- Haematology Standard regimens
- Head and Neck palliative chemo algorithm
- Head and Neck cancer standard regimens
- Head and Neck chemoradiotherapy chemo algorithm
- Lung cancer standard regimens
- Mesothelioma
- NSCLC - CRT
- NSCLC - Palliative
- Oesophageal cancers
- Oesophagogastric
- Ovarian cancer chemo algorithm
- pNET algorithm
- Pancreatic cancer
- Prostate cancer chemo algorithm
- Renal cell cancer chemo algorithm
- Sarcoma standard regimens - adopted from London
- SCLC - Extensive Disease
- SCLC - Limited Disease
- Squamous oesophageal cancers
- Standard regimens for breast cancer
- Standard regimens for colorectal cancer
- Upper GI standard regimens
- Urology standard regimens
- Vulva-Vagina cancer chemo algorithm
Nutrition and blood
oral ergocalciferol preparations
Musculoskeletal joint diseases
- consensus statement on the choice of bisphosphonate
- amifampidrine (Firdapse®) commissioning statement
- Biologics Pathway for Rheumatoid Arthritis in Dorset 2013
Eye
Guidelines currently unavailable. They will be added here when released.
Ear, nose and oropharynx
Guidelines currently unavailable. They will be added here when released.
Skin
Immunological products and vaccines
Guidelines currently unavailable. They will be added here when released.
Anaesthesia
Guidelines currently unavailable. They will be added here when released.
